Arryhthmias Flashcards

1
Q

Shockable rhythms

A

>

Ventricular tachycardia

> Ventricular fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non-shockable rhythms

A

>

Pulseless electrical activity (all electrical activity except VF/VT, including sinus rhythm without a pulse)
Asystole (no significant electrical activity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute management of Supraventricular Tachycardias (SVT)

A

o vagal manoeuvres: e.g. Valsalva manoeuvre, carotid sinus massage
o intravenous adenosine 6mg → 12mg → 12mg: contraindicated in asthmatics - verapamil is a preferable option
o electrical cardioversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of Atrial Flutter

A

Treatment is similar to atrial fibrillation:

  1. Rate/rhythm control - beta blockers/cardioversion
  2. Treat the reversible underlying condition
  3. Radiofrequency ablation of the re-entrant rhythm
  4. Anticoagulation based on CHA2DS2VASc score
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ECG changes seen for Atrial Flutter

A

Saw tooth u waves on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adenosine adverse effects

A

o chest pain
o bronchospasm
o transient flushing
o can enhance conduction down accessory pathways, resulting in increased ventricular rate (e.g. WPW syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adenosine contraindications

A

It should be avoided in asthmatics due to possible bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adenosine mechanism of action

A

Works by slowing cardiac conduction primarily though the AV node. It interrupts the AV node / accessory pathway during SVT and “resets” it back to sinus rhythm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adenosine method of delivery

A

Adenosine should ideally be infused via a large-calibre cannula due to its short half-life,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Wolff-Parkinson White Syndrome

A

Caused by an extra electrical pathway connecting the atria and ventricles. Normally there is only one pathway connecting the atria and ventricles called the atrio-ventricular node.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the name of the extra pathway that is present in Wolff-Parkinson White Syndrome?

A

Bundle of Kent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of Wolff-Parkinson White Syndrome

A

Radiofrequency ablation of the accessory pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ECG changes for Wolff-Parkinson White Syndrome

A
  • Short PR interval (< 0.12 seconds)
  • Wide QRS complex (> 0.12 seconds)
  • “Delta wave” which is a slurred upstroke on the QRS complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Torsades de pointes

A

A type of polymorphic (multiple shape) ventricular tachycardia. It translates from French as “twisting of the tips”, describing the ECG characteristics.

When a patient develops Torsades de pointes it will either terminate spontaneously and revert back to sinus rhythm or progress into ventricular tachycardia. Usually they are self-limiting but if they progress to VT it can lead to a cardiac arrest.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What arrhythmia is a patient at risk of developing with prolonged QT intervals?

A

Torsades de pointes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes of Long QT intervals

A
  • Long QT Syndrome (inherited)
  • Medications (antipsychotics, citalopram, flecainide, sotalol, amiodarone, macrolide antibiotics)
  • Electrolyte Disturbance (hypokalaemia, hypomagnesaemia, hypocalcaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute Management of Torsades de pointes

A
  1. Correct the cause (electrolyte disturbances or medications)
  2. Magnesium infusion (even if they have a normal serum magnesium)
  3. Defibrillation if VT occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Long Term Management of Prolonged QT Syndrome

A

>

Avoid medications that prolong the QT interval
Correct electrolyte disturbances
Beta blockers (not sotalol)
Pacemaker or implantable defibrillator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ventricular ectopics

A

Premature ventricular beats caused by random electrical discharges from outside the atria.

Patients often present complaining of random, brief palpitations (“an abnormal beat”).

20
Q

ECG characteristics for Ventricular ectopic beats

A

They can be diagnosed by ECG and appear as individual random, abnormal, broad QRS complexes on a background of a normal ECG.

21
Q

Management of Ventricular ectopics

A
  1. Check bloods for anaemia, electrolyte disturbance and thyroid abnormalities
  2. Reassurance and no treatment in otherwise healthy people
  3. Seek expert advice in patients with background heart conditions or other concerning features or findings (e.g. chest pain, syncope, murmur, family history of sudden death)
22
Q

First-degree heart block

A

Occurs where there is delayed atrioventricular conduction through the AV node.

Despite this, every atrial impulse leads to a ventricular contraction, meaning every p wave results in a QRS complex.

On an ECG this presents as a PR interval greater than 0.20 seconds (5 small or 1 big square).

23
Q

Second-degree heart block

A

Where some of the atrial impulses do not make it through the AV node to the ventricles. This means that there are instances where p waves do not lead to QRS complexes. There are several patterns of second-degree heart block; Mobitz type 1 & 2, 2:1 block etc.

24
Q

Wenckebach’s phenomenon (Mobitz Type 1)

A

On an ECG this will show up as an increasing PR interval until the P wave no longer conducts to ventricles. This culminates in absent QRS complex after a P wave. The PR interval then returns to normal but progressively becomes longer again until another QRS complex is missed. This cycle repeats itself.

25
Q

Mobitz Type 2

A

This is where there is intermitted failure or interruption of AV conduction. This results in missing QRS complexes. There is usually a set ratio of P waves to QRS complexes, for example 3 P waves to each QRS complex would be referred to as a 3:1 block. The PR interval remains normal. There is a risk of asystole with Mobitz Type 2.

26
Q

What is the risk associated with Mobitz Type 2 heart block?

A

There is a risk of asystole with Mobitz Type 2.

27
Q

2:1 Block

A

This is where there are 2 P waves for each QRS complex. Every second p wave is not a strong enough atrial impulse to stimulate a QRS complex. It can be caused by Mobitz Type 1 or Mobitz Type 2 and it is difficult to tell which.

28
Q

Third-degree heart block

A

This is referred to as complete heart block. This is no observable relationship between P waves and QRS complexes. There is a significant risk of asystole.

29
Q

What is the risk associated with third degree heart block?

A

There is a significant risk of asystole with third-degree heart block.

30
Q

Treatment for Bradycardias / AV Node Blocks

A

Stable: Observe

Unstable or risk of asystole (i.e. Mobitz Type 2, complete heart block or previous asystole):
First line: Atropine 500mcg IV

31
Q

What conditions have a high risk of asystole?

A

i.e. Mobitz Type 2, complete heart block or previous asystole

32
Q

Atropine mechanism of action

A

Antimuscarinic medication and works by inhibiting the parasympathetic nervous system. This leads to side effects of pupil dilatation, urinary retention, dry eyes and constipation.

33
Q

Ventricular tachycardia (VT)

A

Broad-complex tachycardia originating from a ventricular ectopic focus. It has the potential to precipitate ventricular fibrillation and hence requires urgent treatment.

34
Q

What are the two sub-types of VT?

A
  1. monomorphic VT: most commonly caused by myocardial infarction
  2. polymorphic VT: A subtype of polymorphic VT is Torsades de pointes which is precipitated by prolongation of the QT interval.
35
Q

What condition is associated with monomorphic VT?

A

myocardial infarction

36
Q

What condition is associated with poymorphic VT?

A

Torsades de pointes which is precipitated by prolongation of the QT interval.

37
Q

Congenital causes of prolonged QT interval

A

Jerrell-Lange-Nielsen syndrome (includes deafness and is due to an abnormal potassium channel)

Romano-Ward syndrome (no deafness)

38
Q

What drugs cause prolonged QT intervals?

A
>	amiodarone, sotalol, class 1a antiarrhythmic drugs
>	tricyclic antidepressants, fluoxetine
>	chloroquine
>	terfenadine
>	erythromycin
39
Q

Management of VT

A

If the patient has adverse signs (systolic BP < 90 mmHg, chest pain, heart failure) then immediate cardioversion is indicated.

In the absence of such signs antiarrhythmics may be used. If these fail, then electrical cardioversion may be needed with synchronised DC shocks

40
Q

Examples of Class 1 anti-arrhythmic drugs

A

Class IA drugs: Quinidine, Amiodarone, Procainamide, Disopyramide.

Class IB drugs: Lidocaine, Mexiletine, Tocainide. …

Class IC drugs: Flecainide, Propafenone, Encainide, Moricizine

41
Q

Examples of Class II anti-arrhythmic drugs

A

Beta blockers: Metoprolol, Carvedilol, Atenolol, Propranolol, Bisoprolol.

42
Q

Examples of Class III anti-arrhythmic drugs

A

amiodarone, dronedarone, sotalol, ibutilide, dofetilide, and bretylium.

43
Q

Class III anti-arrhythmic drugs - mechanism of action

A

As a generalization, class III antiarrhythmics prolong cardiac action potentials, resulting in an increase in the effective refractory period. With the exception of ibutilide, which slows outward Na+ currents during repolarization, the class III drugs block potassium channels.

44
Q

Class I anti-arrhythmic drugs - mechanism of action

A

These drugs bind to and block the fast sodium channels that are responsible for the rapid depolarization (phase 0) of fast-response cardiac action potentials.

45
Q

Class IV anti-arrhythmic drugs - mechanism of action

A

Slow non-dihydropyridine calcium channel blockers. They decrease conduction through the AV node, and shorten phase two (the plateau) of the cardiac action potential. They thus reduce the contractility of the heart, so may be inappropriate in heart failure.

46
Q

Examples of Class IV anti-arrhythmic drugs

A

Verapamil, Diltiazem